Table 1.

Demographic information.

	Total n = 178 n (%)
Age in years at initiation of atropine
Average (range)	7.8 (2 months–22 years)
<1 year	21 (11.8%)
1–<3 years	26 (14.6%)
3–<12 years	80 (44.9%)
>12 years	51 (28.7%)
Gender
Male	96 (54%)
Female	82 (46%)
Underlying Diagnosis
Cerebral Palsy	98 (55.1%)
Genetic/syndromic disorder	35 (19.7%)
Neuromuscular disease	17 (9.6%)
Neurodegenerative condition	11 (6.2%)
Brain injury	5 (2.8%)
Developmental disorder	4 (2.2%)
Multiple congenital anomalies	4 (2.2%)
Unknown/other	4 (2.2%)